Breast cancer stem cells: An update

Journal of Clinical Pathology

Volumn 66, Issue 6, 2013, Pages 485-490

  Iqbal, Jabed ^a   Chong, Pek Yoon ^a   Tan, Puay Hoon ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CD44V ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; MICRORNA; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENESIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIDE POPULATION CELL;

BREAST CANCER; CANCER STEM CELLS; MOLECULAR ONCOLOGY;

BREAST NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84878275887     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201304     Document Type: Review

References (81)

1. Takahashi R-U, Takeshita F, Fujiwara T, et al. Cancer stem cells in breast cancer. Cancers 2011;3:1311-28.
2. Battula VK, Shi Y, Evans KW, et al. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest 2012;122:2066-78.
3. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res 2006;66:9339-44.
4. Croker AK, Allan AL. Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 2008;12:374-90. (Pubitemid 351555122)
5. Allan AL, Vantyghem SA, Tuck AB, et al. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis 2007;26:87-98.
6. Li F, Tiede B, Massague J, et al. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007;17:3-14. (Pubitemid 46096419)
7. Kucia M, Ratajczak MZ. Stem cells as a two-edged sword - from regeneration to tumor formation. J Physiol Pharmacol 2006;57:5-16. (Pubitemid 46548788)
8. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
9. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:1-12.
10. In Stem Cell Information [World Wide Web site]. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services, 2011.
11. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8. (Pubitemid 36418143)
12. Ibrahim SF, Diercks AH, van den Petersen TW, et al. Kinetic analyses as a critical parameter in de fining the side population (SP) phenotype. Exp Cell Res 2007;313:1921-6. (Pubitemid 46653868)
13. Wu C, Alman BA. Side population cells in human cancers. Cancer Lett 2008;268:1-9.
14. Liu H, Patel MR, Prescher JA, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci USA 2010;107:18115-20.
15. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8. (Pubitemid 37187480)
16. Wright MH, Calcagno AM, Salcido CD. Brca1 breast tumors contain distinct CD44 +/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008;10:R10.
17. Liu TJ, Sun BC, Zhao XL, et al. CD133 (+) cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Oncogene 2012;epub.
18. Alison MR, Guppy NJ, Lim SML, et al. Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose? J Pathol 2010;222:335-44.
19. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67. (Pubitemid 350056407)
20. Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 2009;100:1062-8.
21. Hwang-Verslues WW, Kuo WH, Chang PH, et al. Multiple lineagesof human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 2009;4:e8377.
22. Yesim G-PY, Harikrishna NH, Badve S. Biomarkers for breast cancer stem cells: the challenges ahead. Biomarkers Med 2011;5:661-71.
23. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007;11:259-73. (Pubitemid 46349843)
24. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/ progenitor cells. Genes Dev 2003;17:1253-7.
25. Raouf A, Zhao Y, To K, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008;3:109-18.
26. Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356:217-26. (Pubitemid 46143225)
27. Creighton CJ, Li X, Landis M, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009;106:13820-25.
28. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507. (Pubitemid 351601215)
29. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009;138:592-603.
30. Yu F, Yao H, Zhu P, et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007;131:1109-23. 62.
31. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links in flammation to cell transformation. Cell 2009;139:693-706.
32. Gaiano N, Fishell G. The role of notch in promoting glial and neural stem cell fates. Ann Rev Neurosci 2002;25:417-90.
33. Uyttendaele H, Soriano JV, Montesano R, et al. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev Biol 1998;196:204-17. (Pubitemid 28198847)
34. Soriano JV, Uyttendaele H, Kitajewski J, et al. Expression of an activated Notch4 (int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. Int J Cancer 2000;86:652-9. (Pubitemid 30249875)
35. Schroeder JA, Adriance MC, McConnell EJ, et al. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J Biol Chem 2002;277:22692-98. (Pubitemid 34967248)
36. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11. (Pubitemid 33041634)
37. Hahn H, Wicking C, Zaphiropoulos PG. Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51. (Pubitemid 26192135)
38. Morrison BJ, Schmidt CW, Lakhani SR, et al. Breast cancer stem cells: implications for therapy of breast cancer. Breast Cancer Res 2008;10:210.
39. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008;100:672-9. EGFR
40. Farnie G, Clarke RB, Spence K, et al . Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst. 2007;99:616-27. (Pubitemid 47073543)
41. Battula VK, Shi Y, Evans KW, et al. GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest 2012;122:2066-78.
42. Battula VL, Evans KW, Hollier BG, et al. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 2010;28:1435-45.
43. Mani SA, Guo W, Liao M-J, et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell 2008;133:704-15. (Pubitemid 351636299)
44. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
45. Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007;10:791-9. (Pubitemid 47463670)
46. Bjerkvig R, Tysnes BB, Aboody KS, et al . The origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005;11:899-904. (Pubitemid 41746034)
47. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;12:895-902. (Pubitemid 37500174)
48. Adams JM, Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res 2008;11:4018-21.
49. Gökmen-Polar Y, Nakshatri H, Badve S. Biomarkers for breast cancer stem cells: the challenges ahead. Biomarkers Med 2011;5:661-71.
50. Kim HJ, Kim MJ, Ahn SH, et al. Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status. Breast 2011;20:78-85.
51. Horiguchi K, Toi M, Horiguchi S, et al. Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients. J Med Dent Sci 2010;57:165-75.
52. Giatromanolaki A, Sivridis E, Fiska A, et al. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol 2011;28:745-52.
53. Stingl J, Eirew P, Ricketson I, et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006;439:993-7. (Pubitemid 43292419)
54. Nakshatri H. Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame? Breast Cancer Res 2010;12:105.
55. Nakshatri H, Srour EF, Badve S. Breast cancer stem cells and intrinsic subtypes: controversies rage on. Curr Stem Cell Res Ther 2009;4:50-60.
56. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67. (Pubitemid 350056407)
57. Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010;140:62-73.
58. Croker AK, Goodale D, Chu J, et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2009;13:2236-52.
59. Neumeister V, Agarwal S, Bordeaux J, et al. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol 2010;176:2131-8.
60. Vaillant F, Asselin-Labat ML, Shackleton M, et al. The mammary progenitor marker CD61/b3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008;68:7711-17.
61. Liu JC, Deng T, Lehal RS, et al. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 2007;67:8671-81. (Pubitemid 47437442)
62. Zhang M, Behbod F, Atkinson RL, et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 2008;68:4674-82.
63. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/ progenitor cells. Genes Dev 2003;17:1253-70. (Pubitemid 36583168)
64. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008;10:R25.
65. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2003;100:672-9.
66. Rizzo P, Osipo C, Foreman K, et al. Rational targeting of Notch signaling in cancer. Oncogene 2008;27:5124-31.
67. Chen B, Dodge ME, Wei TW, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009;5:100-7.
68. Curtin CJ, Lorenzi MV. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 2010;1:563-6.
69. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-84. (Pubitemid 40488633)
70. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009;138:645-59.
71. Lu D, Carson DA. Inhibition of Wnt signaling and cancer stem cells. Oncotarget 2011;2:587.
72. Osipo C, Patel P, Rizzo P, et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 2008;27:5019-32.
73. Takabe N, Harris PJ, Warren RQ, et al. Targeting cancer stem cells by inhibiting Wnt, Notch and HedgeHog pathways. Nat Rev Clin Oncol 2011;(8):97-106.
74. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells. Nature 2008;456:593-8.
75. Resetkova E, Reis-Filho JS, Jain RK, et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 2010;123:97-108.
76. Badve S, Nakshatri H. Breast-cancer stem cells - beyond semantics. Lancet Oncol 2012;13:e43-48.
77. Federici G, Espina V, Liotta L, et al. Breast cancer stem cells: a new target for therapy. Oncology 2011;25.
78. Jian CJ, Li Y, Tzong-Shiue Yu T-S, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012;488:522-6.
79. Driessens G, Beck B, Caauwe A, et al. Defining the mode of tumour growth by clonal analysis. Nature 2012;488:527-30.
80. Schepers AG, Snippert HJ, Stange DE, et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012;337:730-5.
81. Spike BT, Engle DD, Lin JC, et al. A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 2012;10:183-97.